HTG Announces Appointments of John Wineman as Vice President New Business Development–Western Region and Thomas Vasicek, Ph.D. as Vice President Clinical Programs and Product Innovation TUCSON, Ariz. – HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™), today announced the appointments of John Wineman as Vice President New Business Development, Western Region and Thomas […]
Enzo Biochem’s Clinical Lab Takes Major Step in Becoming National Provider of Predictive Diagnostics
Pennsylvania Grants Lab License to Operate, With Several Others Pending NEW YORK – In the first of several moves to expand the Company’s position as a national provider of esoteric and high value diagnostics, Enzo Biochem, Inc. /quotes/comstock/13*!enz/quotes/nls/enz (ENZ 3.67, +0.12, +3.38%) announced today that its Enzo Clinical Labs division has been awarded a license […]
XTAG Cystic Fibrosis 60 kit V2 offers the most comprehensive genetic screening for newborns and potential parents. New test detects up to 6 genetic mutations, including those common in African-American and Hispanic populations. AUSTIN, Texas – Luminex Corporation (Nasdaq: LMNX), the worldwide leader in multiplexed solutions, today announced the full commercial launch of its xTAG(R) […]
Basel, 23 – Roche announced today that it has signed an agreement under which Ventana Medical Systems Inc., a member of the Roche Group, will acquire 100 percent of BioImagene, Inc., a privately held company based in Sunnyvale, California. The purchase price is approximately 100 million US dollars on a debt-free basis. The transaction is […]
Product to Be Introduced in Australia, India, New Zealand, Singapore and Taiwan for In Vitro Diagnostic Use CARLSBAD, Calif. – LifeTechnologies Corporation (NASDAQ: LIFE) today announced that its Applied Biosystems(TM) 3500 Dx Series Genetic Analyzers, the first CE IVD-marked capillary electrophoresis system for nucleic acid analysis, are now available for sale in Australia, India, New […]
PMA Pathway Chosen to Maximize Value of Pre-Symptomatic Ovarian Cancer Screening Test SUNNYVALE, Calif. – Arrayit Corporation /quotes/comstock/11k!aryc (ARYC 0.29, 0.00, 0.00%) , a leader in life sciences and healthcare technology, announces today that the company has chosen the Premarket Approval (PMA) pathway for its OvaDx(R) Pre-Symptomatic Ovarian Cancer Screening Test. While the standard for […]
New Paper Published in Epidemiology, Biomarkers, & Prevention Research Peabody, Mass. – Called the silent killer, ovarian cancer is one of the most insidious and hardest to detect diseases. It is the leading cause of death from gynecologic cancers in the United States and, because it presents no obvious symptoms, it is often detected too […]
New scientific instrument will support institute’s efforts to combat malaria and advance research to control and prevent the disease. AUSTIN, Texas – Luminex Corporation (Nasdaq: LMNX), the worldwide leader in multiplexed solutions, today announced it has donated the first commercial unit of its newly launched MAGPIX(R) instrument to Professor Peter Siba and his scientific team […]
Appoints Judd Jessup as Full-Time CEO IRVINE, Calif. – CombiMatrix Corporation (Nasdaq:CBMX) today reported financial results for the three month period ended June 30, 2010 and provided operational updates on its strategic restructuring plan. Key highlights for the second quarter and through the date of this release include: — 51% increase in diagnostic lab revenues […]
Baltimore, MD – BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that it has received “Moderate Complexity” status from the U.S. Food and Drug Administration, under the Clinical Laboratory Improvement Amendments (CLIA), for the BD MAXTM GBS Assay for Group B Streptococcus (GBS) on the BD MAX™ System. With […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
